Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Respiration, Artificial | 14 | 2020 | 22116 | 0.63 | Why? |
| Fluid Therapy | 4 | 2020 | 628 | 0.57 | Why? |
| Positive-Pressure Respiration | 9 | 2020 | 1160 | 0.51 | Why? |
| Steroids | 1 | 2016 | 904 | 0.40 | Why? |
| Dexamethasone | 1 | 2020 | 2055 | 0.38 | Why? |
| Shock, Septic | 3 | 2017 | 1313 | 0.37 | Why? |
| Acute Lung Injury | 4 | 2018 | 904 | 0.35 | Why? |
| Hypoxia | 4 | 2018 | 3626 | 0.35 | Why? |
| Ventilators, Mechanical | 1 | 2020 | 2193 | 0.35 | Why? |
| Glucocorticoids | 2 | 2020 | 4431 | 0.30 | Why? |
| Pulmonary Gas Exchange | 2 | 2020 | 414 | 0.20 | Why? |
| Atracurium | 1 | 2019 | 19 | 0.20 | Why? |
| Vasoconstrictor Agents | 3 | 2020 | 714 | 0.19 | Why? |
| Pragmatic Clinical Trials as Topic | 1 | 2020 | 350 | 0.19 | Why? |
| Re-Epithelialization | 1 | 2018 | 29 | 0.18 | Why? |
| Neuromuscular Blocking Agents | 1 | 2019 | 121 | 0.18 | Why? |
| High-Frequency Ventilation | 1 | 2017 | 57 | 0.17 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.16 | Why? |
| Vasopressins | 1 | 2017 | 70 | 0.16 | Why? |
| Blood Gas Analysis | 2 | 2018 | 893 | 0.16 | Why? |
| Sepsis | 3 | 2018 | 3517 | 0.15 | Why? |
| Respiratory Mechanics | 1 | 2020 | 585 | 0.15 | Why? |
| Regeneration | 1 | 2018 | 429 | 0.14 | Why? |
| Respiratory Insufficiency | 3 | 2021 | 7301 | 0.14 | Why? |
| Expert Testimony | 1 | 2017 | 658 | 0.13 | Why? |
| Pulmonary Alveoli | 1 | 2018 | 867 | 0.12 | Why? |
| Secondary Prevention | 1 | 2017 | 762 | 0.11 | Why? |
| Combined Modality Therapy | 2 | 2019 | 3395 | 0.11 | Why? |
| Angiotensin II | 1 | 2017 | 601 | 0.11 | Why? |
| Precision Medicine | 1 | 2021 | 1477 | 0.11 | Why? |
| Tidal Volume | 3 | 2018 | 565 | 0.11 | Why? |
| Ventilator-Induced Lung Injury | 3 | 2017 | 260 | 0.10 | Why? |
| Primary Prevention | 1 | 2017 | 778 | 0.10 | Why? |
| Treatment Failure | 3 | 2020 | 2106 | 0.10 | Why? |
| Intensive Care Units | 6 | 2020 | 29594 | 0.10 | Why? |
| Lung Transplantation | 2 | 2018 | 1554 | 0.10 | Why? |
| Shock | 1 | 2017 | 1868 | 0.10 | Why? |
| Radiography | 1 | 2017 | 1576 | 0.10 | Why? |
| Humans | 37 | 2021 | 930598 | 0.09 | Why? |
| Troponin T | 1 | 2014 | 771 | 0.09 | Why? |
| Pulmonary Fibrosis | 1 | 2018 | 1068 | 0.09 | Why? |
| Extracorporeal Membrane Oxygenation | 4 | 2020 | 5002 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2021 | 3629 | 0.08 | Why? |
| Mesenchymal Stem Cell Transplantation | 1 | 2018 | 1322 | 0.08 | Why? |
| Critical Illness | 4 | 2020 | 17281 | 0.08 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 1510 | 0.08 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.08 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.08 | Why? |
| Hospital Mortality | 6 | 2020 | 22087 | 0.08 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.07 | Why? |
| Oxygen | 1 | 2018 | 3715 | 0.07 | Why? |
| Adult | 17 | 2020 | 244371 | 0.07 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.06 | Why? |
| Double-Blind Method | 3 | 2020 | 5988 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Aged | 14 | 2020 | 215776 | 0.06 | Why? |
| Middle Aged | 16 | 2020 | 270681 | 0.06 | Why? |
| Male | 19 | 2020 | 367725 | 0.06 | Why? |
| Female | 19 | 2020 | 380317 | 0.06 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.06 | Why? |
| Organ Dysfunction Scores | 2 | 2018 | 1475 | 0.06 | Why? |
| Renal Replacement Therapy | 2 | 2020 | 1530 | 0.05 | Why? |
| Neuromuscular Blockade | 1 | 2019 | 66 | 0.05 | Why? |
| Intention to Treat Analysis | 1 | 2020 | 673 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.05 | Why? |
| Rosuvastatin Calcium | 1 | 2018 | 89 | 0.05 | Why? |
| Chest Wall Oscillation | 1 | 2017 | 17 | 0.04 | Why? |
| Catecholamines | 1 | 2017 | 66 | 0.04 | Why? |
| Partial Pressure | 1 | 2018 | 279 | 0.04 | Why? |
| Vasodilator Agents | 1 | 2020 | 344 | 0.04 | Why? |
| Conscious Sedation | 1 | 2019 | 222 | 0.04 | Why? |
| Prone Position | 2 | 2020 | 1861 | 0.04 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.04 | Why? |
| Single-Blind Method | 1 | 2020 | 1283 | 0.04 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.04 | Why? |
| Reference Standards | 1 | 2020 | 1163 | 0.04 | Why? |
| Length of Stay | 1 | 2014 | 11042 | 0.04 | Why? |
| United States | 2 | 2020 | 46150 | 0.04 | Why? |
| APACHE | 1 | 2018 | 682 | 0.04 | Why? |
| Time | 1 | 2018 | 631 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2018 | 1008 | 0.04 | Why? |
| Calcitonin | 1 | 2017 | 201 | 0.04 | Why? |
| Drug Therapy, Combination | 2 | 2020 | 7268 | 0.04 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2018 | 6543 | 0.04 | Why? |
| Treatment Outcome | 5 | 2020 | 51732 | 0.04 | Why? |
| Goals | 1 | 2018 | 335 | 0.04 | Why? |
| Randomized Controlled Trials as Topic | 3 | 2018 | 10649 | 0.03 | Why? |
| Survival Analysis | 2 | 2018 | 7592 | 0.03 | Why? |
| Random Allocation | 1 | 2016 | 773 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2020 | 1647 | 0.03 | Why? |
| Hypotension | 1 | 2017 | 392 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2018 | 1654 | 0.03 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.03 | Why? |
| Critical Care | 1 | 2017 | 14081 | 0.03 | Why? |
| Data Interpretation, Statistical | 1 | 2017 | 657 | 0.03 | Why? |
| Erythrocyte Transfusion | 1 | 2017 | 386 | 0.03 | Why? |
| Renal Insufficiency | 1 | 2020 | 810 | 0.03 | Why? |
| Prospective Studies | 4 | 2018 | 43301 | 0.03 | Why? |
| Nutrition Assessment | 1 | 2017 | 527 | 0.03 | Why? |
| Nutritional Support | 1 | 2017 | 447 | 0.03 | Why? |
| Oximetry | 1 | 2017 | 658 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2017 | 14232 | 0.03 | Why? |
| Early Diagnosis | 1 | 2021 | 2443 | 0.03 | Why? |
| Patient Care Planning | 1 | 2017 | 582 | 0.03 | Why? |
| Resuscitation | 1 | 2017 | 638 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Intercellular Adhesion Molecule-1 | 1 | 2011 | 189 | 0.03 | Why? |
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2011 | 229 | 0.03 | Why? |
| Pulmonary Surfactant-Associated Protein D | 1 | 2011 | 129 | 0.02 | Why? |
| Patient Positioning | 1 | 2020 | 1505 | 0.02 | Why? |
| Lung | 1 | 2017 | 31049 | 0.02 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Diabetes Mellitus | 2 | 2020 | 8207 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Smoking | 1 | 2020 | 3358 | 0.02 | Why? |
| Lung Diseases | 1 | 2020 | 2361 | 0.02 | Why? |
| Patient Selection | 1 | 2021 | 4560 | 0.02 | Why? |
| Diabetes Complications | 1 | 2018 | 2358 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2018 | 3088 | 0.02 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.02 | Why? |
| Interleukin-8 | 1 | 2011 | 964 | 0.02 | Why? |
| von Willebrand Factor | 1 | 2011 | 668 | 0.02 | Why? |
| Odds Ratio | 1 | 2016 | 5861 | 0.02 | Why? |
| Anti-Bacterial Agents | 2 | 2017 | 10083 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2021 | 5883 | 0.02 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.02 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.01 | Why? |
| Logistic Models | 1 | 2016 | 9089 | 0.01 | Why? |
| Biomarkers | 2 | 2018 | 23361 | 0.01 | Why? |
| Risk Assessment | 2 | 2018 | 25439 | 0.01 | Why? |
| Models, Statistical | 1 | 2018 | 5312 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| Italy | 1 | 2020 | 38444 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2011 | 9537 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Prognosis | 1 | 2011 | 32490 | 0.01 | Why? |
Thompson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(151)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(444)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_